Bupropion Hcl Er (xl) Tablet, Extended Release
Product Images NDC 70756-830

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hcl Er (xl) (NDC 70756-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vvv (Ee47c513 8459 4292 B727 111b0bd1dbcc 01)

Vvv (Ee47c513 8459 4292 B727 111b0bd1dbcc 01)
Chemical structure of bupropion hydrochloride (BUPROPION HCl), showing a chlorophenyl ring connected to a ketone and a tert-butylamine group with an associated HCl molecule.*
FDA Label Image

Bup (Ee47c513 8459 4292 B727 111b0bd1dbcc 02)

Bup (Ee47c513 8459 4292 B727 111b0bd1dbcc 02)
Label for buPROPion Hydrochloride Extended-Release Tablets (XL) 450 mg, oral tablet by Lifestar Pharma LLC. The label shows the product name, strength, dosage form, and directions for use. It indicates a package size of 30 tablets and cautions about safety seals and storage. The label includes a barcode and manufacturer address in Mahwah, NJ, with product origin noted as India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.